The muscular dystrophies

British Medical Journal

Volumn 317, Issue 7164, 1998, Pages 991-995

  Emery, Alan E H ^a,b  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCLE PROTEIN;

ATTITUDE; DISEASE CLASSIFICATION; DUCHENNE MUSCULAR DYSTROPHY; GENE ISOLATION; GENETIC COUNSELING; HETEROZYGOTE DETECTION; HUMAN; MOLECULAR GENETICS; MUSCLE ATROPHY; MUSCLE CONTRACTURE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; PHYSIOTHERAPY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RESPIRATORY FUNCTION; REVIEW;

FORECASTING; GENETIC COUNSELING; HUMANS; MUSCULAR DYSTROPHIES;

EID: 0032505556     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Walton JN, Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain 1954;77:169-231.
2. Walton JN. Muscular dystrophy: some recent advances in knowledge. BMJ 1964;i:1271-4.
3. Walton JN. Muscular dystrophy: some recent advances in knowledge. BMJ 1964;i:1344-8.
4. Murray JM, Davies, KE, Harper PS, Meredith L, Mueller CR, Williamson R. Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature 1982;300:69-71.
5. Kunkel LM, Monaco AP, Middlesworth W, Ochs HD, Latt SA. Specific cloning of DNA fragments absent from DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A 1985;82:4778-82.
6. Ray PN, Belfall B, Duff C, Logan C, Kean V, Thompson MW, et al. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature 1985;318:672-5.
7. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell 1987;51:919-28.
8. Sugita H, Arahata K, Ishiguro T, Suhara Y, Tsukahara T, Ishiura S, et al. Negative immunostaining of Duchenne muscular dystrophy (DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA. Proc Jpn Acad 1988;64:37-9.
9. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AHM, Belfall B, Klamut HJ, et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 1988;333:466-9.
10. Emery AEH. Duchenne muscular dystrophy. 2nd ed. Oxford: Oxford University Press, 1993.
11. Bakker E, van Broeckhoven C, Bonten EJ, van de Vooren MJ, Veenema H, van Hul W, et al. Germ line mosaicism and Duchenne muscular dystrophy mutations. Nature 1987;329:554-8.
12. Holding C, Bentley D, Roberts R, Bobrow M, Matthew C. Development and validation of laboratory procedures for preimplantation diagnosis of Duchenne muscular dystrophy. J Med Genet 1993;30:903-9.
13. Padberg GW, Lunt PW, Koch M, Fardeau M. Facioscapulohumeral muscular dystrophy. In: Emery AEH, ed. Diagnostic criteria for neuromuscular disorders. 2nd ed. London: Royal Society of Medicine, 1997:9-15.
14. Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 1990;336:651-3.
15. Bushby KMD. Towards the classification of the autosomal recessive limb girdle muscular dystrophies. Neuromuscul Disord 1996;6:439-41.
16. Beckmann JS, Bushby KMD. Advances in the molecular genetics of the limb girdle type of autosomal recessive progressive muscular dystrophy. Curr Opin Neurol 1996;9:389-93.
17. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP, Angelini C. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 1997;336:618-24.
18. Welander L. Myopathia distalis tarda hereditaria. Acta Med Scand 1951;141(suppl 265):1-124.
19. Laing NG, Laing BA, Meredith C, Wilton SD, Robbins P, Honeyman K, et al. Autosomal dominant distal myopathy: linkage to chromosome 14. Am J Hum Genet 1995;56:422-7.
20. Somer H, Paetau A, Udd B. Distal myopathies. In: Emery AEH, ed. Neuromuscular disorders: clinical and molecular genetics. Chichester: Wiley, 1998:181-201.
21. Bouchard J-P, Brais P, Tomé FMS, eds. Proceedings of the 1st international symposium on oculopharyngeal muscular dystrophy (Québec, Canada, 22-23 September 1995). Neuromuscul Disord 1997;7(suppl 1):S1-106.
22. Brais B, Bouchard J-P, Xie Y-G, Rochefort DL, Chrétien N, Tomé FMS, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nature Genetics 1998;18:164-7.
23. Tomé FMS, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci Paris Life Sci 1994;317:351-7.
24. Guicheney P, Vignier N, Helbling-Leclerc A, Nissinen M, Zhang X, Cruaud C, et al. Genetics of laminin α 2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosis. Neuromuscul Disord 1997;7:180-6.
25. Tomé FMS, Guicheney P, Fardeau M. Congenital muscular dystrophies. In: Emery AEH, ed. Neuromuscular disorders: clinical and molecular genetics. Chichester: Wiley, 1998:21-57.
26. Dubowitz V. Workshop report: 50th ENMC international workshop on congenital muscular dystrophy. Neuromusc Disord 1997;7:539-47.
27. Metzinger L, Blake DJ, Squier MV, Anderson LVB, Deconinck AE, Nawrotzki R, et al. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Hum Mol Genet 1997;6:1185-91.
28. Brown SC, Lucy JA. Functions of dystrophin. In: Brown SC, Lucy JA, eds. Dystrophin: gene, protein and cell biology. Cambridge: Cambridge University Press, 1997:163-200.
29. Cartegni L, di Barletta MR. Barresi R, Squarzoni S, Sabatelli P, Maraldi N, et al. Heart specific localization of emerin. Hum Mol Genet 1997;6:2257-64.
30. Emery AEH. Muscular dystrophy - the facts. Oxford: Oxford University Press, 1996.
31. Dubowitz V. Workshop report: 47th ENMC international workshop on treatment of muscular dystrophy. Neuromuscul Disord 1997;7:261-7.
32. Howell JMcC, Karpati G, Kakulas BA, eds. Proceedings of a workshop on gene therapy for Duchenne muscular dystrophy (Perth. Australia, 30-31 May 1996). Neuromuscul Disord 1997;7:273-366.
33. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 1996;384:349-53.
34. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, et al. Utrophin-dystrophin deficient mice as a model for Duchenne muscular dystrophy. Cell 1997;90:717-27.